Pfizer raised its sales forecast for its Covid-19 vaccine by $2bn to $34bn on Tuesday, as higher prices offset a slowdown in demand outside the US.
輝瑞(Pfizer)周二將其新冠疫苗的銷售預期上調20億美元，至340億美元，原因是價格上漲抵消了美國以外需求放緩的影響。
您已閱讀5%（208字），剩余95%（4163字）包含更多重要信息，訂閱以繼續探索完整內容，并享受更多專屬服務。